HIV vaccine triggers broadly neutralizing antibodies in 44% of primates

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS.

This HIV vaccine is the first to generate a high number of "broadly neutralizing" virus-fighting antibodies in primates.

The research is published in the journal Nature. ...